SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-132402
Filing Date
2020-12-04
Accepted
2020-12-04 16:02:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2037515d1_s3.htm S-3 223546
2 EXHIBIT 5.1 tm2037515d1_ex5-1.htm EX-5.1 7055
3 EXHIBIT 23.1 tm2037515d1_ex23-1.htm EX-23.1 2325
4 EXHIBIT 23.2 tm2037515d1_ex23-2.htm EX-23.2 3574
5 GRAPHIC tm2037515d1_s3img001.jpg GRAPHIC 30678
  Complete submission text file 0001104659-20-132402.txt   280049
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251138 | Film No.: 201369903
SIC: 2834 Pharmaceutical Preparations